G Sakoulas

Summary

Affiliation: Sharp Memorial Hospital
Country: USA

Publications

  1. pmc Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
    Marin L Schweizer
    Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
    BMC Infect Dis 11:279. 2011
  2. doi request reprint Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience
    George Sakoulas
    Division of Infectious Diseases, New York Medical College, Valhalla, New York, USA
    Clin Ther 31:1936-45. 2009
  3. doi request reprint Clinical outcomes with daptomycin: a post-marketing, real-world evaluation
    G Sakoulas
    Division of Infectious Diseases, New York Medical College, Valhalla, New York, NY, USA
    Clin Microbiol Infect 15:11-6. 2009
  4. pmc Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains
    G Sakoulas
    Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    J Clin Microbiol 39:3946-51. 2001

Collaborators

  • Jack Brown
  • Kenneth C Lamp
  • H S Gold
  • Marin L Schweizer
  • J Kristie Johnson
  • Jon P Furuno
  • Eli N Perencevich
  • Kerri A Thom
  • Anthony D Harris
  • Michelle D Shardell
  • Jessina C McGregor
  • Sara E Cosgrove

Detail Information

Publications4

  1. pmc Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
    Marin L Schweizer
    Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
    BMC Infect Dis 11:279. 2011
    ..The outcome of interest for this study was 30-day in-hospital mortality...
  2. doi request reprint Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience
    George Sakoulas
    Division of Infectious Diseases, New York Medical College, Valhalla, New York, USA
    Clin Ther 31:1936-45. 2009
    ..Daptomycin is most commonly used as a second-line treatment. Previous studies have not differentiated the effect of prior antibiotic therapy on daptomycin clinical outcomes...
  3. doi request reprint Clinical outcomes with daptomycin: a post-marketing, real-world evaluation
    G Sakoulas
    Division of Infectious Diseases, New York Medical College, Valhalla, New York, NY, USA
    Clin Microbiol Infect 15:11-6. 2009
    ..However, similar treatment outcomes were observed when daptomycin was used as first-line therapy or as salvage therapy, demonstrating the effectiveness of daptomycin in the treatment of these patients...
  4. pmc Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains
    G Sakoulas
    Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    J Clin Microbiol 39:3946-51. 2001
    ..We conclude that the accuracy of the MRSA-Screen latex agglutination method for detection of PBP 2a approaches the accuracy of PCR and is more accurate than any susceptibility testing method used alone for the detection of MRSA...